Cue Biopharma, Inc.
CUEUS売上高
$27M
百万USD
営業利益
$-27M
百万USD
純利益
$-27M
百万USD
ROE
-100.6%
最新FY
EPS
$-0.28
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $2M | $-13M | - |
| FY2021 | Q2 | $3M | $-10M | - |
| FY2021 | Q3 | $2M | $-13M | - |
| FY2021 | FY | $15M | $-44M | - |
| FY2022 | Q1 | $1M | $-14M | - |
| FY2022 | Q2 | $0M | $-13M | - |
| FY2022 | Q3 | $0M | $-11M | $-0.31 |
| FY2022 | FY | $1M | $-53M | $-1.49 |
| FY2023 | Q1 | $0M | $-13M | $-0.29 |
| FY2023 | Q2 | $1M | $-13M | $-0.29 |
| FY2023 | Q3 | $2M | $-11M | $-0.24 |
| FY2023 | FY | $5M | $-51M | $-1.11 |
| FY2024 | Q1 | $2M | $-12M | $-0.25 |
| FY2024 | Q2 | $3M | $-10M | $-0.20 |
| FY2024 | Q3 | $3M | $-9M | $-0.17 |
| FY2024 | FY | $9M | $-41M | $-0.72 |
| FY2025 | Q1 | $0M | $-12M | $-0.17 |
| FY2025 | Q2 | $3M | $-8M | $-0.09 |
| FY2025 | Q3 | $2M | $-7M | $-0.07 |
| FY2025 | FY | $27M | $-27M | $-0.28 |
| FY2026 | Q1 | $6M | $-5M | $-1.08 |
財務データ
| 指標 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| 売上高 | $1M | $3M | $3M | $15M | $1M | $5M | $9M | $27M |
| 営業利益 | $-39M | $-37M | $-45M | $-44M | $-53M | $-52M | $-41M | $-27M |
| 純利益 | $-39M | $-37M | $-45M | $-44M | $-53M | $-51M | $-41M | $-27M |
| 総資産 | $45M | $72M | $100M | $83M | $91M | $62M | $32M | $42M |
| 純資産 | - | - | - | - | - | - | - | - |
| 自己資本 | $34M | $55M | $79M | $65M | $66M | $37M | $17M | $26M |
| 営業CF | $-26M | $-31M | $-32M | $-39M | $-42M | $-40M | $-36M | $-22M |
| EPS | - | - | - | - | $-1.49 | $-1.11 | $-0.72 | $-0.28 |
| BPS | $1.64 | $2.05 | $2.59 | $1.98 | $1.52 | $0.76 | $0.28 | $0.27 |
| ROE | -114.7% | -67.2% | -56.8% | -67.4% | -80.7% | -136.8% | -232.4% | -100.6% |